Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis

Background: Several phase-II trials have been designed to evaluate tyrosine kinase inhibitors (TKIs), in particular, pazopanib in neuroendocrine neoplasia (NEN), but its efficacy has not yet been demonstrated in a randomised-controlled Phase III trial. A systematic review of the published clinical t...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Bongiovanni, Alberto, Liverani, Chiara, Recine, Federica, Fausti, Valentina, Mercatali, Laura, Vagheggini, Alessandro, Spadazzi, Chiara, Miserocchi, Giacomo, Cocchi, Claudia, Di Menna, Giandomenico, De Vita, Alessandro, Severi, Stefano, Nicolini, Silvia, Ibrahim, Toni
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
Oncology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154093/
https://ncbi.nlm.nih.gov/pubmed/32318336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00414
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料